non-Hodgkin's lymphoma protocol 8503

United Kingdom Children's Cancer Study Group (UKCCSG) continuous, intensive leukemia type regimen consisting of the above compounds; includes cranial irradiation and continuing chemotherapy for 2 years

Also Known As:

NHL protocol 8503; UKALLXD ALL protocol, Medical Research Council; UKCCSG NHL protocol 8503

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - non-Hodgkin's lymphoma protocol 8503
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - non-Hodgkin's lymphoma protocol 8503
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - non-Hodgkin's lymphoma protocol 8503
Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Hydrolases: 2166
    - Amidohydrolases: 43
      - Asparaginase: 2285
        non-Hodgkin's lymphoma protocol 8503
Organic Chemicals: 133
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        non-Hodgkin's lymphoma protocol 8503
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienetriols
        Prednisolone: 12013
        non-Hodgkin's lymphoma protocol 8503
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        non-Hodgkin's lymphoma protocol 8503
Heterocyclic Compounds: 198
Pharmaceutical Preparations
- Drug Combinations: 5337
  - Sulfamethoxazole Drug Combination Trimethoprim: 5321
    - non-Hodgkin's lymphoma protocol 8503